# 2025-19705: Dentist Faces DEA Hammer in Drug Prescribing Showdown

2025-19705, Lawrence Michael Willis, D.D.S.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-10-30, effective 2025-12-01; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19705
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19705
- Title: Lawrence Michael Willis, D.D.S.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 48898
- Published: 2025-10-30
- Effective: 2025-12-01
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Dentist Faces DEA Hammer in Drug Prescribing Showdown

## Summary

Dr. Lawrence Michael Willis from Colorado lost his DEA registration because he didn’t follow state rules about checking the Prescription Drug Monitoring Program. He didn’t ask for a hearing in time, so the government revoked his registration by default. This means he can’t legally handle controlled substances anymore, effective immediately, which could impact his dental practice and income.

## Effects PRIA read

- DEA Registration Revoked; Colorado Renewals Denied: cost, high. The DEA revoked Lawrence Michael Willis's Certificate of Registration No. AW1335822 and denied any pending applications to renew or modify that registration as well as any other pending application for additional registration in Colorado. The Agency found he failed to register for and query the Col…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19705 on federalregister.gov](https://www.federalregister.gov/documents/2025/10/30/2025-19705/lawrence-michael-willis-dds-decision-and-order)
- [2025-19705 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-10-30/pdf/2025-19705.pdf)

## Related
- [Previous: 2025-19704, Committee and Quarterly Board Meetings](https://policyrisk.com/federal-register/2025-19704)
- [Next: 2025-19707, Dawn Evert, N.P.; Decision and Order](https://policyrisk.com/federal-register/2025-19707)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19705 (as of 2026-06-08).
